MyFinsight
Home
Blog
About
Short-term investments
$9,761,994
(-50.29%↓ Y/Y)
Cash and cash
equivalents
$7,076,533
(588.16%↑ Y/Y)
Tax and other
receivables
$1,815,079
Prepaid expenses and
other current assets
$1,127,482
(17.80%↑ Y/Y)
Collaboration receivables
$1,091,385
(-54.86%↓ Y/Y)
Prepaid collaboration
expenses
$390,042
Total current assets
$21,262,515
(-14.05%↓ Y/Y)
Intangible assets and
in-process r&d, net
$2,063,100
(-69.15%↓ Y/Y)
Operating lease
right-of-use assets
$260,753
(-25.29%↓ Y/Y)
Property and equipment,
net
$99,637
(-6.74%↓ Y/Y)
Other assets
$85,379
(39.95%↑ Y/Y)
Restricted cash
$4,706
(5.49%↑ Y/Y)
Total assets
$23,776,090
(-25.57%↓ Y/Y)
Total liabilities and
stockholders equity
$23,776,090
(-25.57%↓ Y/Y)
Total stockholders
equity
$16,856,689
(-23.82%↓ Y/Y)
Total liabilities
$6,919,401
(-29.52%↓ Y/Y)
Accumulated deficit
-$158,714,270
(-7.44%↓ Y/Y)
Accumulated other
comprehensive loss
-$255,798
(-4.08%↓ Y/Y)
Additional paid-in capital
$175,544,810
(3.37%↑ Y/Y)
Total non-current
liabilities
$4,548,906
(-31.41%↓ Y/Y)
Total current
liabilities
$2,370,495
(-25.60%↓ Y/Y)
Common stock, 0.01 par
value 150,000,000...
$281,943
(3.65%↑ Y/Y)
Preferred stock, 0.01 par
value 10,000,000...
$4
(0.00%↑ Y/Y)
Contingent consideration
$3,036,157
(-34.06%↓ Y/Y)
Deferred collaboration
revenue
$1,250,000
(0.00%↑ Y/Y)
Non-current operating lease
liabilities
$160,597
(-44.06%↓ Y/Y)
Deferred tax liability
$102,152
(-79.18%↓ Y/Y)
Accrued expenses
$1,981,573
(-22.00%↓ Y/Y)
Accounts payable
$216,497
(-23.37%↓ Y/Y)
Operating lease
liabilities
$172,425
(20.30%↑ Y/Y)
Back
Back
Balance Sheet
KIORA PHARMACEUTICALS INC (KPHMW)
KIORA PHARMACEUTICALS INC (KPHMW)
source: myfinsight.com